- Home
- ATNM vs MOBX Comparison
ATNM vs MOBX Comparison
Compare ATNM & MOBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNM
- MOBX
- Stock Information
- Founded
- ATNM 2000
- MOBX 2020
- Country
- ATNM United States
- MOBX United States
- Employees
- ATNM N/A
- MOBX N/A
- Industry
- ATNM Biotechnology: Pharmaceutical Preparations
- MOBX
- Sector
- ATNM Health Care
- MOBX
- Exchange
- ATNM Nasdaq
- MOBX Nasdaq
- Market Cap
- ATNM 50.2M
- MOBX 57.1M
- IPO Year
- ATNM N/A
- MOBX N/A
- Fundamental
- Price
- ATNM $1.58
- MOBX $1.00
- Analyst Decision
- ATNM Strong Buy
- MOBX
- Analyst Count
- ATNM 2
- MOBX 0
- Target Price
- ATNM $4.50
- MOBX N/A
- AVG Volume (30 Days)
- ATNM 116.8K
- MOBX 1.8M
- Earning Date
- ATNM 11-13-2025
- MOBX 08-13-2025
- Dividend Yield
- ATNM N/A
- MOBX N/A
- EPS Growth
- ATNM N/A
- MOBX N/A
- EPS
- ATNM N/A
- MOBX N/A
- Revenue
- ATNM N/A
- MOBX $10,984,000.00
- Revenue This Year
- ATNM N/A
- MOBX N/A
- Revenue Next Year
- ATNM N/A
- MOBX N/A
- P/E Ratio
- ATNM N/A
- MOBX N/A
- Revenue Growth
- ATNM N/A
- MOBX 180.13
- 52 Week Low
- ATNM $1.03
- MOBX $0.55
- 52 Week High
- ATNM $2.41
- MOBX $2.47
- Technical
- Relative Strength Index (RSI)
- ATNM 42.17
- MOBX 55.71
- Support Level
- ATNM $1.56
- MOBX $0.79
- Resistance Level
- ATNM $1.64
- MOBX $0.87
- Average True Range (ATR)
- ATNM 0.06
- MOBX 0.09
- MACD
- ATNM -0.01
- MOBX 0.02
- Stochastic Oscillator
- ATNM 6.67
- MOBX 63.58
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.
About MOBX Mobix Labs Inc.
Mobix Labs Inc. specializes in designing, developing, and selling components and systems for wireless and wired connectivity, radio frequency (RF) technologies, switching, and electromagnetic interference (EMI) filtering solutions. The company serves markets, including commercial, industrial, automotive, medical, aerospace, defense, and others.